FTGRX | VTSAX | FTGRX / VTSAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 24 years | - |
Gain YTD | 19.841 | 16.921 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.24B | 1.72T | 0% |
Annual Yield % from dividends | 0.52 | 1.35 | 38% |
Returns for 1 year | 29.70 | 25.89 | 115% |
Returns for 3 years | 41.19 | 21.34 | 193% |
Returns for 5 years | 76.99 | 82.99 | 93% |
Returns for 10 years | 58.62 | 179.72 | 33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FEKFX | 16.32 | 0.02 | +0.12% |
Fidelity Equity-Income K6 | |||
FBTTX | 31.30 | -0.05 | -0.16% |
Fidelity Advisor Biotechnology M | |||
TANDX | 37.82 | -0.06 | -0.16% |
Castle Tandem Institutional | |||
SHISX | 73.00 | -0.27 | -0.37% |
BlackRock Health Sciences Opps Svc | |||
AGYGX | 13.27 | -0.05 | -0.38% |
American Century Focused Global Gr Y |